Waterloo Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.37M Sell
3,663
-497
-12% -$504K 0.24% 97
2025
Q4
$4.47M Buy
4,160
+630
+18% +$602K 0.32% 73
2025
Q3
$2.69M Buy
3,530
+248
+8% +$185K 0.2% 111
2025
Q2
$2.56M Buy
3,282
+88
+3% +$68.4K 0.21% 112
2025
Q1
$2.64M Buy
3,194
+851
+36% +$708K 0.25% 103
2024
Q4
$1.81M Sell
2,343
-221
-9% -$183K 0.19% 119
2024
Q3
$2.27M Sell
2,564
-155
-6% -$139K 0.25% 100
2024
Q2
$2.46M Buy
2,719
+1,502
+123% +$1.2M 0.3% 82
2024
Q1
$947K Sell
1,217
-49
-4% -$34.9K 0.12% 156
2023
Q4
$738K Buy
1,266
+778
+159% +$454K 0.12% 166
2023
Q3
$262K Sell
488
-598
-55% -$308K 0.08% 159
2023
Q2
$509K Buy
+1,086
New +$455K 0.15% 89

Other funds holding LLY

Waterloo Capital's LLY Position: Q1 2026 in Review

Waterloo Capital reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $504K and leaving 3,663 shares worth $3.37M. The position accounts for 0.24% of the portfolio, ranked #97.

Waterloo Capital first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.47M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Waterloo Capital held 3,663 shares of Eli Lilly worth $3.37M as of Q1 2026.
  • Waterloo Capital sold 497 Eli Lilly shares in Q1 2026, an estimated $504K.
  • Eli Lilly made up 0.24% of Waterloo Capital's portfolio in Q1 2026, its #97 holding.
  • Waterloo Capital first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
  • Waterloo Capital's Eli Lilly position peaked at $4.47M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.